CVS Health Is Still A Buy - Cramer's Lightning Round (10/11/18) [Seeking Alpha]
OptiNose, Inc. (OPTN)
Last optinose, inc. earnings: 3/5 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.optinose.com
Company Research
Source: Seeking Alpha
Oct. 12, 2018 7:12 AM ET | | Includes: AEP , ARNC , CVS , D , OGS , OPTN , VOD , VZ by: SA Editor Mohit Manghnani Summary Vodafone has been a laggard. OptiNose is a specialty pharmacy company, and Cramer thinks this is a tough business. Arconic's fate depends on the buyer. Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Thursday, October 11 . Bullish Calls Verizon Communications (NYSE: VZ ): It's a fine stock. Buy it. ONE Gas (NYSE: OGS ): It's a good, regulated natural gas utility. Cramer likes Dominion Energy (NYSE: D ) and American Electric Power (NYSE: AEP ) too. CVS Health (NYSE: CVS ): Cramer said he was shocked at the CFO's departure , but he still likes the stock after the merger. Bearish Calls Arconic (NYSE: ARNC ): It's at $21. If they don't get a buyer, the stock goes to $17. If they do get a buyer, they go to $23. So it's $3 up, $3 down. For me, that means don't buy. V
Show less
Read more
Impact Snapshot
Event Time:
OPTN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OPTN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OPTN alerts
High impacting OptiNose, Inc. news events
Weekly update
A roundup of the hottest topics
OPTN
News
- OptiNose (NASDAQ:OPTN) shareholders have endured a 87% loss from investing in the stock five years ago [Yahoo! Finance]Yahoo! Finance
- Optinose to Present at the Needham Virtual Healthcare ConferenceGlobeNewswire
- OptiNose, Inc. (NASDAQ: OPTN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.MarketBeat
- OptiNose, Inc. (NASDAQ: OPTN) had its price target raised by analysts at Lake Street Capital from $3.00 to $4.00. They now have a "buy" rating on the stock.MarketBeat
- OptiNose granted FDA nod to expand labeling for sinusitis therapy [Seeking Alpha]Seeking Alpha
OPTN
Earnings
- 3/7/24 - Beat
OPTN
Sec Filings
- 3/19/24 - Form 4
- 3/19/24 - Form 4
- 3/19/24 - Form 4
- OPTN's page on the SEC website